Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=66f66779569e4469b60a9a2ec04006a0&url=https%3A%2F%2Fwww.pharmiweb.com%2Fpress-release%2F2024-09-27%2Fformycon-and-fresenius-kabi-receive-european-commission-approval-for-fyb202otulfi-ustekinumab-fo&c=13132495782564781479&mkt=de-de
Author :
Publish date : 2024-09-27 00:38:00
Copyright for syndicated content belongs to the linked Source.
Formycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases
